These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
230 related articles for article (PubMed ID: 7903551)
1. Transfer of lymphocytic choriomeningitis disease in beta 2-microglobulin-deficient mice by CD4+ T cells. Quinn DG; Zajac AJ; Frelinger JA; Muller D Int Immunol; 1993 Oct; 5(10):1193-8. PubMed ID: 7903551 [TBL] [Abstract][Full Text] [Related]
2. LCMV-specific, class II-restricted cytotoxic T cells in beta 2-microglobulin-deficient mice. Muller D; Koller BH; Whitton JL; LaPan KE; Brigman KK; Frelinger JA Science; 1992 Mar; 255(5051):1576-8. PubMed ID: 1347959 [TBL] [Abstract][Full Text] [Related]
3. Fas-dependent CD4+ cytotoxic T-cell-mediated pathogenesis during virus infection. Zajac AJ; Quinn DG; Cohen PL; Frelinger JA Proc Natl Acad Sci U S A; 1996 Dec; 93(25):14730-5. PubMed ID: 8962123 [TBL] [Abstract][Full Text] [Related]
4. Virus-specific, CD8+ major histocompatibility complex class I-restricted cytotoxic T lymphocytes in lymphocytic choriomeningitis virus-infected beta2-microglobulin-deficient mice. Quinn DG; Zajac AJ; Hioe CE; Frelinger JA J Virol; 1997 Nov; 71(11):8392-6. PubMed ID: 9343195 [TBL] [Abstract][Full Text] [Related]
6. CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection. Matloubian M; Concepcion RJ; Ahmed R J Virol; 1994 Dec; 68(12):8056-63. PubMed ID: 7966595 [TBL] [Abstract][Full Text] [Related]
7. Oestrogen influences CD4+ T-lymphocyte activity in vivo and in vitro in beta 2-microglobulin-deficient mice. Muller D; Chen M; Vikingsson A; Hildeman D; Pederson K Immunology; 1995 Oct; 86(2):162-7. PubMed ID: 7490113 [TBL] [Abstract][Full Text] [Related]
8. Vaccination protects beta 2 microglobulin deficient mice from immune mediated mortality but not from persisting viral infection. Hildeman D; Salvato M; Whitton JL; Muller D Vaccine; 1996 Sep; 14(13):1223-9. PubMed ID: 8961509 [TBL] [Abstract][Full Text] [Related]
9. Lymphocytic choriomeningitis virus induces a chronic wasting disease in mice lacking class I major histocompatibility complex glycoproteins. Doherty PC; Hou S; Southern PJ J Neuroimmunol; 1993 Jul; 46(1-2):11-7. PubMed ID: 8103060 [TBL] [Abstract][Full Text] [Related]
10. Beta 2-microglobulin-deficient mice demonstrate class II MHC restricted anti-viral CD4+ but not CD8+ CTL against influenza-sensitized autologous splenocytes. Taylor SF; Bender BS Immunol Lett; 1995 May; 46(1-2):67-73. PubMed ID: 7590931 [TBL] [Abstract][Full Text] [Related]
11. Virus-specific MHC-class II-restricted TCR-transgenic mice: effects on humoral and cellular immune responses after viral infection. Oxenius A; Bachmann MF; Zinkernagel RM; Hengartner H Eur J Immunol; 1998 Jan; 28(1):390-400. PubMed ID: 9485218 [TBL] [Abstract][Full Text] [Related]
12. Evidence for an underlying CD4 helper and CD8 T-cell defect in B-cell-deficient mice: failure to clear persistent virus infection after adoptive immunotherapy with virus-specific memory cells from muMT/muMT mice. Homann D; Tishon A; Berger DP; Weigle WO; von Herrath MG; Oldstone MB J Virol; 1998 Nov; 72(11):9208-16. PubMed ID: 9765468 [TBL] [Abstract][Full Text] [Related]
13. The role of CD4+ T cells in cell-mediated immunity to LCMV: studies in MHC class I and class II deficient mice. Christensen JP; Marker O; Thomsen AR Scand J Immunol; 1994 Oct; 40(4):373-82. PubMed ID: 7939408 [TBL] [Abstract][Full Text] [Related]
14. Antiviral immune responses of lymphocytic choriomeningitis virus-infected mice lacking CD8+ T lymphocytes because of disruption of the beta 2-microglobulin gene. Lehmann-Grube F; Löhler J; Utermöhlen O; Gegin C J Virol; 1993 Jan; 67(1):332-9. PubMed ID: 8093219 [TBL] [Abstract][Full Text] [Related]
15. Pathological changes in the islet milieu precede infiltration of islets and destruction of beta-cells by autoreactive lymphocytes in a transgenic model of virus-induced IDDM. von Herrath M; Holz A J Autoimmun; 1997 Jun; 10(3):231-8. PubMed ID: 9218748 [TBL] [Abstract][Full Text] [Related]
16. High frequency of cross-reactive cytotoxic T lymphocytes elicited during the virus-induced polyclonal cytotoxic T lymphocyte response. Nahill SR; Welsh RM J Exp Med; 1993 Feb; 177(2):317-27. PubMed ID: 8093891 [TBL] [Abstract][Full Text] [Related]
17. Biology of cloned cytotoxic T lymphocytes specific for lymphocytic choriomeningitis virus. VI. Migration and activity in vivo in acute and persistent infection. Byrne JA; Oldstone MB J Immunol; 1986 Jan; 136(2):698-704. PubMed ID: 2416821 [TBL] [Abstract][Full Text] [Related]
18. In vivo treatment with a MHC class I-restricted blocking peptide can prevent virus-induced autoimmune diabetes. von Herrath MG; Coon B; Lewicki H; Mazarguil H; Gairin JE; Oldstone MB J Immunol; 1998 Nov; 161(9):5087-96. PubMed ID: 9794447 [TBL] [Abstract][Full Text] [Related]
19. A critical role for neutralizing-antibody-producing B cells, CD4(+) T cells, and interferons in persistent and acute infections of mice with lymphocytic choriomeningitis virus: implications for adoptive immunotherapy of virus carriers. Planz O; Ehl S; Furrer E; Horvath E; Bründler MA; Hengartner H; Zinkernagel RM Proc Natl Acad Sci U S A; 1997 Jun; 94(13):6874-9. PubMed ID: 9192659 [TBL] [Abstract][Full Text] [Related]
20. Mechanism of recovery from acute virus infection. IX. Clearance of lymphocytic choriomeningitis (LCM) virus from the feet of mice undergoing LCM virus-specific delayed-type hypersensitivity reaction. Moskophidis D; Fang L; Gossmann J; Lehmann-Grube F J Gen Virol; 1989 Dec; 70 ( Pt 12)():3305-16. PubMed ID: 2575136 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]